Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
Authors
Keywords
COVID19, Cancer, Oncology, SARS-CoV-2, Vaccine, Seropositivity, Seronegativity, Co-morbidities, Immunoglobulin, IgG
Journal
EUROPEAN JOURNAL OF CANCER
Volume 157, Issue -, Pages 124-131
Publisher
Elsevier BV
Online
2021-09-08
DOI
10.1016/j.ejca.2021.08.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Commentary: SARS-CoV-2 vaccines and cancer patients
- (2021) C. Corti et al. ANNALS OF ONCOLOGY
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. TRANSPLANTATION
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely
- (2021) Ayelet Grupper et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Oncology Practice During the COVID-19 Pandemic
- (2020) Deborah Schrag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
- (2020) Jianbo Tian et al. LANCET ONCOLOGY
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
- (2020) Kunyu Yang et al. LANCET ONCOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to influenza virus vaccination during chemotherapy in patients with breast cancer
- (2011) A. Meerveld-Eggink et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started